Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.6% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Idexx Laboratories
IDXX
$46.2B
| $78.3M | 0.14% |
694,304
+156,900
| +29% | +$16.5M |
|
152
Berkshire Hathaway Class A
BRK.A
$1.11T
| $78.1M | 0.14% |
361
+88
| +32% | +$19.3M |
|
153
Charles River Laboratories
CRL
$13.5B
| $78M | 0.14% |
935,909
+155,800
| +20% | +$13.1M |
|
154
Gen Digital
GEN
$17.4B
| $77.9M | 0.14% |
3,102,038
-400,141
| -11% | -$9.1M |
|
155
Toronto Dominion Bank
TD
$201B
| $77.8M | 0.14% |
1,752,300
+239,200
| +16% | +$10.5M |
|
|
PXD
156
DELISTED
Pioneer Natural Resource Co.
PXD
| $76.7M | 0.14% |
413,388
-14,005
| -3% | -$2.38M |
|
157
Pan American Silver
PAAS
$21.8B
| $76.2M | 0.13% |
4,323,817
-1,521,700
| -26% | -$28.5M |
|
158
Ultrapar
UGP
$6.34B
| $75.9M | 0.13% |
6,935,200
-1,425,400
| -17% | -$15.9M |
|
|
MZTI
159
The Marzetti Company
MZTI
$3.15B
| $75.9M | 0.13% |
574,500
-35,000
| -6% | -$4.57M |
|
160
Booking.com
BKNG
$160B
| $75.6M | 0.13% |
+1,284,975
| New | +$71.6M |
|
161
AutoZone
AZO
$49.7B
| $75.6M | 0.13% |
98,400
+68,700
| +231% | +$53.5M |
|
|
NTRI
162
DELISTED
NutriSystem, Inc.
NTRI
| $75.2M | 0.13% |
2,532,500
+32,600
| +1% | +$919K |
|
163
British American Tobacco
BTI
$122B
| $74.7M | 0.13% |
1,171,000
+98,400
| +9% | +$6.24M |
|
164
Biogen
BIIB
$30.1B
| $74.6M | 0.13% |
238,261
+197,861
| +490% | +$58.6M |
|
|
DD
165
DELISTED
Du Pont De Nemours E I
DD
| $74.1M | 0.13% |
1,106,800
+701,400
| +173% | +$47.6M |
|
166
TSMC
TSM
$2.19T
| $74.1M | 0.13% |
2,422,451
-354,000
| -13% | -$10.1M |
|
167
Eli Lilly
LLY
$1.08T
| $74M | 0.13% |
922,200
-1,269,005
| -58% | -$102M |
|
168
Annaly Capital Management
NLY
$17.4B
| $73.8M | 0.13% |
1,757,527
-914,348
| -34% | -$39.6M |
|
169
Boeing
BA
$184B
| $73.2M | 0.13% |
555,300
+528,000
| +1,934% | +$69.6M |
|
170
Equinor
EQNR
$97.2B
| $72.6M | 0.13% |
4,321,600
-158,698
| -4% | -$2.58M |
|
|
AZPN
171
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $71.8M | 0.13% |
1,534,500
-41,300
| -3% | -$1.93M |
|
|
TFCFA
172
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $71.7M | 0.13% |
2,960,400
+778,400
| +36% | +$19.9M |
|
173
Post Holdings
POST
$3.56B
| $70.2M | 0.12% |
1,390,786
+237,146
| +21% | +$13M |
|
174
Telephone and Data Systems
TDS
$3.84B
| $70.1M | 0.12% |
2,578,792
+171,800
| +7% | +$5.01M |
|
|
TARO
175
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $69.6M | 0.12% |
629,900
+9,000
| +1% | +$1.19M |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.